BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 10464069)

  • 1. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland.
    Kurttio P; Pukkala E; Kahelin H; Auvinen A; Pekkanen J
    Environ Health Perspect; 1999 Sep; 107(9):705-10. PubMed ID: 10464069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers.
    Michaud DS; Wright ME; Cantor KP; Taylor PR; Virtamo J; Albanes D
    Am J Epidemiol; 2004 Nov; 160(9):853-9. PubMed ID: 15496537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the risk of bladder and kidney cancer from exposure to low-levels of arsenic in drinking water, Nova Scotia, Canada.
    Saint-Jacques N; Brown P; Nauta L; Boxall J; Parker L; Dummer TJB
    Environ Int; 2018 Jan; 110():95-104. PubMed ID: 29089168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.
    Tsuji JS; Alexander DD; Perez V; Mink PJ
    Toxicology; 2014 Mar; 317():17-30. PubMed ID: 24462659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Well water radioactivity and risk of cancers of the urinary organs.
    Kurttio P; Salonen L; Ilus T; Pekkanen J; Pukkala E; Auvinen A
    Environ Res; 2006 Nov; 102(3):333-8. PubMed ID: 16448644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of arsenic-contaminated drinking-water with prevalence of skin cancer in Wisconsin's Fox River Valley.
    Knobeloch LM; Zierold KM; Anderson HA
    J Health Popul Nutr; 2006 Jun; 24(2):206-13. PubMed ID: 17195561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water.
    Marshall G; Ferreccio C; Yuan Y; Bates MN; Steinmaus C; Selvin S; Liaw J; Smith AH
    J Natl Cancer Inst; 2007 Jun; 99(12):920-8. PubMed ID: 17565158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis.
    Mink PJ; Alexander DD; Barraj LM; Kelsh MA; Tsuji JS
    Regul Toxicol Pharmacol; 2008 Dec; 52(3):299-310. PubMed ID: 18783726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic in drinking water and risk of urinary tract cancer: a follow-up study from northeastern Taiwan.
    Chen CL; Chiou HY; Hsu LI; Hsueh YM; Wu MM; Wang YH; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):101-10. PubMed ID: 20056628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inorganic arsenic in drinking water and bladder cancer: a meta-analysis for dose-response assessment.
    Chu HA; Crawford-Brown DJ
    Int J Environ Res Public Health; 2006 Dec; 3(4):316-22. PubMed ID: 17159272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of arsenic in drinking-water and cutaneous lesions in Inner Mongolia.
    Guo X; Liu Z; Huang C; You L
    J Health Popul Nutr; 2006 Jun; 24(2):214-20. PubMed ID: 17195562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence.
    Saint-Jacques N; Parker L; Brown P; Dummer TJ
    Environ Health; 2014 Jun; 13():44. PubMed ID: 24889821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan.
    Yang CY; Chiu HF; Chang CC; Ho SC; Wu TN
    Environ Res; 2005 May; 98(1):127-32. PubMed ID: 15721893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder cancer and arsenic exposure: differences in the two populations enrolled in a study in southwest Taiwan.
    Lamm SH; Byrd DM; Kruse MB; Feinleib M; Lai SH
    Biomed Environ Sci; 2003 Dec; 16(4):355-68. PubMed ID: 15011967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ingested arsenic, characteristics of well water consumption and risk of different histological types of lung cancer in northeastern Taiwan.
    Chen CL; Chiou HY; Hsu LI; Hsueh YM; Wu MM; Chen CJ
    Environ Res; 2010 Jul; 110(5):455-62. PubMed ID: 19735913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA.
    Meliker JR; Slotnick MJ; AvRuskin GA; Schottenfeld D; Jacquez GM; Wilson ML; Goovaerts P; Franzblau A; Nriagu JO
    Cancer Causes Control; 2010 May; 21(5):745-57. PubMed ID: 20084543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term impact of arsenic in drinking water on bladder cancer health care and mortality rates 20 years after end of exposure.
    Fernández MI; López JF; Vivaldi B; Coz F
    J Urol; 2012 Mar; 187(3):856-61. PubMed ID: 22248521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of arsenic levels in drinking water and the prevalence rate of skin lesions in Bangladesh.
    Tondel M; Rahman M; Magnuson A; Chowdhury IA; Faruquee MH; Ahmad SA
    Environ Health Perspect; 1999 Sep; 107(9):727-9. PubMed ID: 10464073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study.
    Chen Y; Graziano JH; Parvez F; Liu M; Slavkovich V; Kalra T; Argos M; Islam T; Ahmed A; Rakibuz-Zaman M; Hasan R; Sarwar G; Levy D; van Geen A; Ahsan H
    BMJ; 2011 May; 342():d2431. PubMed ID: 21546419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-control study of arsenic in drinking water and kidney cancer in uniquely exposed Northern Chile.
    Ferreccio C; Smith AH; Durán V; Barlaro T; Benítez H; Valdés R; Aguirre JJ; Moore LE; Acevedo J; Vásquez MI; Pérez L; Yuan Y; Liaw J; Cantor KP; Steinmaus C
    Am J Epidemiol; 2013 Sep; 178(5):813-8. PubMed ID: 23764934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.